Clearpoint Neuro is trading at $9.52, up 5.25%, with no company-specific announcement identified to explain the October 27 move.

  • The Nasdaq rose 0.96% and the S&P 500 rose 0.51%; broader positive sentiment may have contributed, though a direct link is unconfirmed.
  • Clearpoint Neuro is scheduled to report Q3 2026 results after the market close on October 28.
  • Volume and intraday trading activity were not verified.